Afya Announces Closing of $150 Million Investment from the SoftBank Latin America Fund
Get Alerts AFYA Hot Sheet
Join SI Premium – FREE
NOVA LIMA, MINAS GERAIS, Brazil, May 03, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), the largest medical education group in Brazil, today announced that SoftBank Latin America Fund (“Softbank”) closed on its purchase of US$150 million of Afya’s Series A perpetual convertible preferred shares set forth in the Certificate of Designations. In addition, Crescera Educacional II Fundo de Investimento em Participações Multiestratégia and the Esteves Family also closed on the sale of 2,270,208 Class A common shares to SoftBank. In connection with such sale, Paulo Passoni from Softbank will be appointed as a board member of Afya within the next 30 days.
Softbank and its affiliates beneficially own approximately 8.4% of the total shares of the company (on an as-converted basis for the Series A perpetual convertible preferred shares).
About Afya
Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering digital products to help doctors enhance their healthcare services through their whole career.
Contact: Investor Relations: [email protected]
Source: AfyaSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SCHLITTERBAHN NEW BRAUNFELS WATERPARK TO OPEN NEW CHILDREN’S AREA FEATURING THE WORLD’S FIRST WATER COASTER FOR KIDS
- HELIOS® by VirtualHealth Named Bronze Stevie® Award Winner in 2024 American Business Awards®
- Workspot Names Brad Tompkins New CEO as Company Readies for Rapid Scale-up
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!